Results 11 to 20 of about 13,127 (165)

Medication Burden: Beyond Counts to Recognize Polypharmacy as an Inherent Part of Living With Chronic Kidney Disease. [PDF]

Basic Clin Pharmacol Toxicol
ABSTRACT Medication burden in older patients with chronic kidney disease (CKD) is substantial, and simple medication counts are insufficient for identifying those at elevated risk of inappropriate prescribing. This study characterized medication burden by assessing the number of medications, potentially inappropriate medications (PIMs) and ...
Houlind MB, Juul-Larsen HG, Strandhave C, Westergaard N, Olesen AE.   +4 more
europepmc   +2 more sources

Pantoprazole Inhibited Metastasis and Angiogenesis Through Wnt/β-Catenin Signaling Pathway in Gastric Cancer Stem-Like Cells [PDF]

Advanced Biomedical Research
Background: The research on different therapy approaches is critical to find an efficient gastric cancer treatment. The processes of new drug production are very expensive and also take about 15 years.
Hassan Akrami, Mohammad Reza Fattahi, Kiumars Mehdizadeh, Diba Borzabadi Farahani, Behrouz Moradi   +4 more
doaj   +2 more sources

COMPARITIVE STUDY BTWEEN PANTOPRAZOLE AND RANITIDINE ON SOME CARDIOVASCULAR PREPARATIONS [PDF]

Al-Azhar Journal of Pharmaceutical Sciences, 2012
Because of the abundant use of proton pump inhibitors (PPIs) and  histamine H2- receptors antagonists ( H2RAs) and considering the hazards of high intravenous (IV) dosing especially in critically ill intensive care unit ( ICU)  patients and in view of ...
Maryam Hammoda
doaj   +1 more source

Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer

Frontiers in Oncology, 2021
The effective and economical therapeutic strategy for metastatic castration-resistant prostate cancer (mCRPC) is still requested from patients, who are not available for Lu-177 or Ra-223 treatment.
Zhoulei Li, Peng He, Yali Long, Gang Yuan, Wanqing Shen, Zhifeng Chen, Bing Zhang, Yue Wang, Dianchao Yue, Christof Seidl, Xiangsong Zhang   +10 more
doaj   +1 more source

Intragastric pH effect of 20 mg of levo-pantoprazole versus 40 mg of racemic pantoprazole the first seven days of treatment in patients with gastroesophageal reflux disease

Revista de Gastroenterología de México (English Edition), 2020
Introduction/aim: Levo-pantoprazole, the S-enantiomer of pantoprazole, is a proton pump inhibitor that has been shown in animal studies to be faster and stronger than its racemic formulation.
J.M. Remes-Troche, F.D. García García, G. Rojas-Loureiro, X. Rivera-Gutiérrez, J. Reyes-Huerta, M. Amieva-Balmori   +5 more
doaj   +1 more source

The effectiveness and cost of lansoprazole and pantoprazole for stress ulcer prophylaxis in intensive care unit [PDF]

Pharmaciana, 2021
The incidence of bleeding is increased in high risk patients with critical conditions in Intensive Care Unit (ICU). Appropriate prophylaxis medicine is necessary to reduce the incidence of stress ulcer bleeding during hospitalization in ICU which further
Mega Octavia, Zullies Ikawati, Tri Murti Andayani   +2 more
doaj   +1 more source

Efecto sobre el pH intragástrico de 20 mg de levopantoprazol versus 40 mg de pantoprazol racémico durante los primeros 7 días de tratamiento en pacientes con enfermedad por reflujo gastroesofágico

Revista de Gastroenterología de México, 2020
Resumen: Introducción/objetivo: El S-enantiómero del pantoprazol, el levopantoprazol, es un inhibidor de la bomba de protones que en estudios animales ha mostrado ser más rápido y potente que su formulación racémica.
J.M. Remes-Troche, F.D. García García, G. Rojas-Loureiro, X. Rivera-Gutiérrez, J. Reyes-Huerta, M. Amieva-Balmori   +5 more
doaj   +1 more source

Electroanalytical sensors-based biogenic synthesized metal oxide nanoparticles for potentiometric assay of pantoprazole sodium

Green Chemistry Letters and Reviews, 2023
Two modified coated membrane sensors were designed and tested. Pantoprazole-phosphotungstate was prepared by a reaction of pantoprazole with phosphotungstic acid in the solvent mediator o-nitrophenyloctyl ether. Two metal oxide nanoparticles nickel oxide
Eman M. Alshehri, Nawal A. Alarfaj, Salma A. Al-Tamimi, Maha F. El-Tohamy   +3 more
doaj   +1 more source

Validação de metodologia analítica por cromatografia líquida para doseamento e estudo da estabilidade de pantoprazol sódico Validation of analytical methodology by hplc for quantification and stability evaluation of sodium pantoprazole

Química Nova, 2007
Pantoprazole is a proton pump inhibitor used in the treatment of digestive ulcers, gastro-esophageal reflux disease and in the eradication of Helicobacter pylori.
Renata Platcheck Raffin, Letícia Marques Colomé, Sílvia Stanisçuaski Guterres, Adriana Raffin Pohlmann   +3 more
doaj   +1 more source

Anaphylaxis caused by taking pantoprazole: case series

European Journal of Case Reports in Internal Medicine, 2023
Introduction: Pantoprazole is one of the most widely used proton pump inhibitors, but anaphylaxis occurs rarely during its use. The purpose of reporting these two cases is to show that pantoprazole is not a drug without problems; it can also cause ...
Skender Telaku, Arber Veliu, Qendrim Zenelaj, Mimoza Telaku, Hajrullah Fejza, Fitim Alidema   +5 more
doaj   +1 more source